Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) shares rose 6.9% during trading on Monday. The stock traded as high as $51.38 and last traded at $51.6030. Approximately 380,510 shares were traded during mid-day trading, a decline of 76% from the average session volume of 1,584,559 shares. The stock had previously closed at $48.29.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on HTFL shares. Piper Sandler restated an “overweight” rating and set a $45.00 price target (up from $38.00) on shares of Heartflow in a report on Friday, August 14th. Canaccord Genuity Group lifted their price objective on shares of Heartflow from $45.00 to $56.00 and gave the stock a “buy” rating in a research report on Tuesday, September 22nd. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Wells Fargo & Company increased their target price on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Finally, Wall Street Zen cut Heartflow from a “buy” rating to a “hold” rating in a research report on Saturday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Heartflow presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.25.
View Our Latest Research Report on Heartflow
Heartflow Trading Up 6.3%
The company has a market cap of $4.46 billion, a PE ratio of -28.05 and a beta of 2.73. The business’s 50-day simple moving average is $47.26 and its 200-day simple moving average is $35.34.
Heartflow (NASDAQ:HTFL – Get Free Report) last issued its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company had revenue of $64.08 million during the quarter. Heartflow’s quarterly revenue was up 47.7% on a year-over-year basis. On average, research analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Heartflow news, CEO John Farquhar sold 38,900 shares of the business’s stock in a transaction dated Monday, October 12th. The stock was sold at an average price of $49.57, for a total value of $1,928,273.00. Following the transaction, the chief executive officer owned 283,014 shares in the company, valued at $14,029,003.98. The trade was a 12.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Vikram Verghese sold 16,766 shares of the business’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $50.75, for a total value of $850,874.50. Following the completion of the transaction, the chief financial officer owned 155,183 shares in the company, valued at $7,875,537.25. This trade represents a 9.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 304,105 shares of company stock worth $14,173,800. Corporate insiders own 7.70% of the company’s stock.
Institutional Investors Weigh In On Heartflow
Several large investors have recently made changes to their positions in the company. GAMMA Investing LLC increased its holdings in Heartflow by 75.1% in the third quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after buying an additional 275 shares during the last quarter. TrueMark Investments LLC lifted its stake in Heartflow by 1.4% in the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock valued at $654,000 after acquiring an additional 379 shares during the last quarter. IFP Advisors Inc lifted its stake in Heartflow by 844.7% in the third quarter. IFP Advisors Inc now owns 803 shares of the company’s stock valued at $40,000 after acquiring an additional 718 shares during the last quarter. Strs Ohio boosted its holdings in Heartflow by 35.3% in the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of Heartflow during the 2nd quarter worth about $53,000.
Heartflow Company Profile
HeartFlow, Inc is a medical technology company focused on improving the diagnosis and management of coronary artery disease. The company develops software and clinical tools that use artificial intelligence, advanced image analysis and data from coronary computed tomography angiography (CCTA) scans to provide noninvasive assessments of blood flow and potential blockages in the heart.
Its principal product is the HeartFlow Analysis, which creates a personalized, three-dimensional model of a patient’s coronary arteries and can estimate the impact of blockages on blood flow.
Read More
- Five stocks we like better than Heartflow
- Illinois Tool Works Faces Headwinds—2 Alternatives Stand Out
- Luxury’s Middle Market Is Cracking—These 3 Stocks Could Win
- Rate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are Diverging
- The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
